Skip to content

Fluid Resuscitation for Pediatric Diabetic Ketoacidosis

Fluid Resuscitation for Pediatric Diabetic Ketoacidosis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01701557
Enrollment
50
Registered
2012-10-05
Start date
2007-11-30
Completion date
2010-06-30
Last updated
2012-10-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Keywords

Ketoacidosis Fluids

Brief summary

Randomized trial to determine if the volume of fluid administration in pediatric patients with DKA impacts the rate of normalization of serum bicarbonate, pH as well as the length of treatment

Detailed description

A randomized trial of two initial volumes of IVF and subsequent administration rates. Group I received 10 mL/kg of NS intravenous bolus over the first hour followed by ¾ NS with potassium replacement at 1.25 times maintenance and Group II received 20 mL/kg of NS intravenous bolus over the first hour followed by ¾ NS with potassium replacement at 1.5 times maintenance. The specific variables measured included demographics (age, gender, and race/ethnicity) and routine laboratory values (pH, pCO2, plasma glucose, electrolytes, bicarbonate, sodium, chloride, BUN. Length of treatment was defined as a time of the hospital stay after the start of IVF infusion.

Interventions

OTHERslow fluid rate

10 mL/kg of NS intravenous bolus over the first hour followed by ¾ NS with potassium replacement at 1.25 times maintenance

OTHERfast fluid rate

20 mL/kg of NS intravenous bolus over the first hour followed by ¾ NS with potassium replacement at 1.5 times maintenance

Sponsors

University of Colorado, Denver
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
1 Days to 18 Years
Healthy volunteers
No

Inclusion criteria

* 1 day to 18 years of age * type 1 diabetes * presence of DKA, as defined by glucose \>250 mg/dl, accumulation of ketone bodies in the blood, and metabolic acidosis (venous pH \< 7.30 or serum bicarbonate \< 15 mmol/L.)

Exclusion criteria

* requirement for additional fluid resuscitation for hemodynamic instability * weight greater than 70 kilograms

Design outcomes

Primary

MeasureTime frameDescription
time to normalization of bicarbonate and pHstart of treatment until resolution of DKA an expected average of 12 to 24 hoursLaboratory parameters were measured hourly for the first 4 hours, and every 2 to3 hours thereafter until acid-base normalization (pH was above 7.3 or the HCO3 was above 15 mmol/L)

Secondary

MeasureTime frameDescription
the length of treatmentdischarge from the hospital, an expected average of 1-2 daysLength of treatment was defined as a time of the hospital stay after the start of IVF infusion

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 14, 2026